Crossmark

Additional benefits of combined ceftriaxone and adipose-derived mesenchymal stem cells on revamping the outcomes in rodent after acute spinal infection

Crossref DOI link: https://doi.org/10.1007/s10735-024-10344-9

Published Online: 2025-01-06

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yin, Tsung-Cheng

Lin, Hung-Sheng

Sung, Pei-Hsun

Chiang, John Y.

Yang, Chien-Hui

Yip, Hon-Kan

Chen, Kuan-Hung
Funding

Funding for this research was provided by:

Kaohsiung Chang Gung Memorial Hospital (CMRPG8M0581)
License Information

Text and Data Mining valid from 2025-01-06

Version of Record valid from 2025-01-06
More Information

Article History

Received: 22 October 2024

Accepted: 19 December 2024

First Online: 6 January 2025

Declarations

:

: All animal procedures were approved by the Institute of Animal Care and Use Committee at Kaohsiung Chang Gung Memorial Hospital (Affidavit of Approval of Animal Use Protocol No. 2020121605) and performed in accordance with the Guide for the Care and Use of Laboratory Animals.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below